COMMUNIQUÉS West-GlobeNewswire

-
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
20/08/2024 -
Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024
20/08/2024 -
Orion Corporation: Managers’ transactions – Liisa Hurme
20/08/2024 -
Legend Senior Living® Assumes Management of Crescent Fields Senior Living Community in Huntingdon Valley, Growing Portfolio to 60
20/08/2024 -
Carilion Clinic further expands quality cardiac care access with latest Philips innovations at new regional cardiovascular institute in Virginia, US
20/08/2024 -
Actuate Therapeutics to Ring the Nasdaq Opening Bell on Friday, August 23, 2024
20/08/2024 -
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
20/08/2024 -
TerrAscend Announces $10 Million Share Repurchase Program
20/08/2024 -
Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak
20/08/2024 -
SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System
20/08/2024 -
AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
20/08/2024 -
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
20/08/2024 -
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
20/08/2024 -
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung
20/08/2024 -
Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
20/08/2024 -
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
20/08/2024 -
Entera Bio to Participate in Upcoming Investor and Scientific Conferences
20/08/2024 -
Immutep Announces Late-Breaking Abstract in Head & Neck Cancer Selected for Oral Presentation at ESMO Congress 2024
20/08/2024 -
Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension
20/08/2024
Pages